title: Treatment of light chain deposition disease with bortezomib and dexamethasone.
authors.forename: Efstathios
authors.initials: E
authors.lastname: Kastritis
authors.forename: Magdalini
authors.initials: M
authors.lastname: Migkou
authors.forename: Maria
authors.initials: M
authors.lastname: Gavriatopoulou
authors.forename: Panos
authors.initials: P
authors.lastname: Zirogiannis
authors.forename: Valsamakis
authors.initials: V
authors.lastname: Hadjikonstantinou
authors.forename: Meletios A
authors.initials: MA
authors.lastname: Dimopoulos
mesh_terms: D000368:Aged; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D003907:Dexamethasone / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010265:Paraproteinemias / Q000188:drug therapy*; D011719:Pyrazines / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib; D003907:Dexamethasone